A central goal of The Academy of Breastfeeding Medicine is the development of clinical protocols for managing common medical problems that may impact breastfeeding success. These protocols serve only as guidelines for the care of breastfeeding mothers and infants and do not delineate an exclusive course of treatment or serve as standards of medical care. Variations in treatment may be appropriate according to the needs of an individual patient.
GoelN, BeasleyD, RajkumarV, et al.Perinatal outcome of illicit substance use in pregnancy—Comparative and contemporary socio-clinical profile in the UK. Eur J Pediatr, 2011; 170:199–205.
3.
Welle-StrandGK, SkurtveitS, JanssonLM, et al.Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants. Acta Paediatr, 2013; 102:1060–1066.
4.
Diagnostic and Statistical Manual of Mental Disorders, 5th ed. American Psychiatric Association, Washington, DC, 2013.
5.
D'ApolitoK. Breastfeeding and substance abuse. Obstet Clin Gynecol, 2013; 56:202–211.
6.
Sachs HC; American Academy of Pediatrics Committee on Drugs. The transfer of drugs and therapeutics into human breast milk: An update on selected topics. Pediatrics, 2013; 132:e796–e809.
7.
RoweH, BakerT, HaleTW. Maternal medication, drug use, and breastfeeding. Pediatr Clin North Am, 2013; 60:275–294.
8.
EidelmanAI, SchanlerR; Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics, 2012; 129:e827–e841.
9.
Appendix A Task Force Ratings. Guide to clinical preventive services: Report of the U.S. Preventive Services Task Force, 2nd edition. Available at www.ncbi.nlm.nih.gov/books/NBK15430/ (accessed February27, 2015).
10.
KaufmanR, PetruchaRA, PittsFN, et al.PCP in amniotic fluid and breast milk: Case report. J Clin Psychiatry, 1983; 44:269–270.
11.
WineckerRE, GoldbergerBA, TebbettIR, et al.Detection of cocaine and its metabolites in breast milk. J Forensic Sci, 2001; 46:1221–1223.
12.
ChasnoffI, LewisDE, SquiresL. Cocaine intoxication in a breast fed infant. Pediatrics, 1987; 80:836–838.
13.
WongS, OrdeanA, KahanM, et al.Substance use in pregnancy. J Obstet Gynaecol Can, 2011; 33:367–384.
14.
Wojnar-HortonRE, KristensenJH, YappP, et al.Methadone distribution and excretion into breast milk of clients in a methadone maintenance programme. Br J Clin Pharmacol, 1997; 44:543–547.
15.
McCarthyJJ, PoseyBL. Methadone levels in human milk. J Hum Lact, 2000; 16:115–120.
16.
BeggEJ, MalpasTJ, HackettLP, et al.Distribution of R- and S-methadone into human milk during multiple, medium to high oral dosing. Br J Clin Pharmacol, 2001; 52:681–685.
17.
BogenDL, PerelJM, HelselJC, et al.Estimated infant exposure to enantiomer-specific methadone levels in breastmilk. Breastfeed Med, 2011; 6:377–384.
18.
Abdel-LatifME, PinnerJ, ClewsS, et al.Effects of breast milk on the severity and outcome of NAS among infants of drug-dependent mothers. Pediatrics, 2006; 117:1163–1169.
19.
JanssonLM, ChooR, VelezML, et al.Methadone maintenance and breastfeeding in the neonatal period. Pediatrics, 2008; 121:106–114.
20.
McQueenKA, Murphy-OikonenJ, GerlachK, et al.The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Adv Neonatal Care, 2011; 11:282–290.
WachmanEM, ByunJ, PhilippBL. Breastfeeding rates among mothers of infants with neonatal abstinence syndrome. Breastfeed Med, 2010; 5:159–164.
25.
DemirciJR, BogenDL, KlionskyY. Breastfeeding and methadone therapy: The maternal experience. Subst Abus, 2014April4 [Epub ahead of print]. doi: 10.1080/08897077.2014.902417.
26.
IlettKF, HackettLP, GowerS, et al.Estimated dose exposure of the neonate to buprenorphine and its metabolite norbuprenorphine via breastmilk during maternal buprenorphine substitution treatment. Breastfeed Med, 2012; 7:269–274.
27.
GrimmD, PaulyE, PoschlJ, et al.Buprenorphine and norbuprenorphine concentrations in human breastmilk samples determined by liquid chromatography-tandem mass spectrometry. Ther Drug Monit, 2005; 27:526–530.
28.
MarquetP, ChevralJ, LavignasseP, et al.Buprenorphine withdrawal syndrome in a newborn. Clin Pharmacol Ther, 1997; 62:569–571.
29.
JohnsonRE, JonesHE, JasinskiDR, et al.Buprenorphine treatment of pregnant opioid dependent women: Maternal and neonatal outcomes. Drug Alcohol Depend, 2001; 63:97–103.
30.
GowerS, BartuA, IlettKF, et al.The wellbeing of infants exposed to buprenorphine via breast milk at 4 weeks of age. J Hum Lact, 2014; 30:217–223.
31.
O'ConnorAB, CollettA, AltoWA, et al.Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy. J Midwifery Womens Health, 2013; 58:383–388.
32.
PatrickSW, SchumacherRE, BenneyworthBD, et al.Neonatal abstinence syndrome and associated health care expenditures. JAMA, 2012; 307:1934–1940.
33.
Centers for Disease Control and Prevention. Opioid pain killers widely prescribed among reproductive age women [press release]. January2015. Available at www.cdc.gov/media/releases/2015/p0122-pregnancy-opioids.html (accessed February23, 2015).
34.
ACOG Committee on Health Care for Underserved Women; American Society of Addiction Medicine. ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol, 2012; 119:1070–1076.
MontgomeryA, HaleTW; The Academy of Breastfeeding Medicine. ABM Clinical Protocol #15: Analgesia and anesthesia for the breastfeeding mother, revised 2012. Breastfeed Med, 2012; 7:547–553.
37.
HendricksonRG, McKeownNJ. Is maternal opioid use hazardous to breast-fed infants?. J Toxicol, 2012; 50:1–14.
38.
MadadiP, KorenG, CairnsJ, et al.Safety of codeine during breastfeeding. Fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. Can Fam Physician, 2007; 53:33–35.
39.
Perez-ReyesM, WallME. Presence of Δ9-tetrahydrocannabinol in human milk. N Engl J Med, 1982; 307:819–820.
40.
HaleTW, RoweHE. Medications and Mothers' Milk, 16th ed. Hale Publishing LP, Plano, TX, 2014.
41.
AstleySJ, LittleRE. Maternal marijuana use during lactation and infant development at one year. Neurotoxicol Teratol, 1990; 12:161–168.
42.
TennesK, AvitableN, BlackardC, et al.Marijuana: Prenatal and postnatal exposure in the human. NIDA Res Monogr, 1985; 59:48–60.
43.
VolkowND, BalerRD, ComptonWM, et al.Adverse health effects of marijuana use. N Engl J Med, 2014; 370:2219–2227.
44.
HillM, ReedK. Pregnancy, breast-feeding, and marijuana: A review article. Obstet Gynecol Surv, 2013; 68:710–718.
45.
CampolongoP, TrezzaV, PalmeryM, et al.Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations. Int Rev Neurobiol, 2009; 85:117–133.
46.
Klonoff-CohenH, Lam-KruglickP. Maternal and paternal recreational drug use and sudden infant death syndrome. Arch Pediatr Adolesc Med, 2001; 155:765–770.
KorenG. Drinking alcohol while breastfeeding. Will it harm my baby?. Can Fam Physician, 2002; 48:39–41.
52.
YangI, HallL. Smoking cessation and relapse challenges reported by postpartum women. MCN Am J Matern Child Nurs, 2004; 39:375–380.
53.
LevittC, ShawE, WongS, et al.Systematic review of the literature on postpartum care: Effectiveness of interventions for smoking relapse prevention, cessation, and reduction in postpartum women. Birth, 2007; 34:341–347.
54.
Texas Tech University Health Sciences Center, Infant Risk Center. Tobacco Use. Available at www.infantrisk.com/content/tobacco-use (accessed February20, 2015).
55.
HortaBL, VictoraCG, MenezesAM, et al.Environmental tobacco smoke and breastfeeding duration. Am J Epidemiol, 1997; 146:128–133.
56.
MyrR. Promoting, protecting, and supporting breastfeeding in a community with a high rate of tobacco use. J Hum Lact, 2014; 20:415–416.
57.
DoreaJG. Maternal smoking and infant feeding: Breastfeeding is better and safer. Matern Child Health J, 2007; 11:287–291.
58.
HeydariG, MasjediM, AhmadyAE, et al.A comparative study on tobacco cessation methods: A quantitative systematic review. Int J Prev Med, 2014; 5:673–678.
